Literature DB >> 18419432

Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact.

Gaston De Serres1, Frédéric Dallaire, Mathieu Côte, Danuta M Skowronski.   

Abstract

BACKGROUND: Since the 1980s, rare cases of rabies in humans in Canada and the United States have been almost exclusively caused by the bat-variant virus.
METHODS: We reviewed indigenously acquired cases of bat-variant rabies in humans in Canada and the United States from 1950 through 2007.
RESULTS: Of 61 cases identified, 5 occurred after organ transplantation and were excluded from further analysis. A bite was reported by 22 (39%) of the case patients, 9 (16%) had a direct contact (i.e., were touched by a bat) but no history of a bite, 6 (11%) found bats in their home (2 [4%] in the room where they slept) but reported no direct contact, and 19 (34%) reported no history of bat exposure whatsoever. With the exception of California (8 cases) and Texas (7 cases), no state or province had >3 cases. Of the case patients, 76% were men, and 40% were 10-29 years of age. The median incubation period was 7 weeks (<10 weeks in 72% of cases). The incidence of bat-variant rabies cases increased from 2.2 per billion person-years in 1950-1989 to 6.7 per billion person-years in 1990-2007. Of 36 case patients with bat rabies described since 1990, 16 had no history of direct bat contact; 2 (13%) of the 16 would have qualified for rabies postexposure prophylaxis on the basis of exposure criteria expanded in 1995 to include bats that were in the same room as a sleeping person. The incidence of rabies for this type of exposure was 0.6 cases per billion person-years.
CONCLUSION: The true preventable proportion of cases and the number needed to treat with rabies postexposure prophylaxis to prevent 1 case would be useful information to inform the current guidelines.

Entities:  

Mesh:

Year:  2008        PMID: 18419432     DOI: 10.1086/586745

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

Review 1.  Travel medicine: what's involved? When to refer?

Authors:  Brian Aw; Suni Boraston; David Botten; Darin Cherniwchan; Hyder Fazal; Timothy Kelton; Michael Libman; Colin Saldanha; Philip Scappatura; Brian Stowe
Journal:  Can Fam Physician       Date:  2014-12       Impact factor: 3.275

2.  Rabies: still a uniformly fatal disease? Historical occurrence, epidemiological trends, and paradigm shifts.

Authors:  Henry M Feder; Brett W Petersen; Kis L Robertson; Charles E Rupprecht
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs.

Authors:  Pieter-Paul A M van Thiel; Rob M A de Bie; Filip Eftimov; Robert Tepaske; Hans L Zaaijer; Gerard J J van Doornum; Martin Schutten; Albert D M E Osterhaus; Charles B L M Majoie; Eleonora Aronica; Christine Fehlner-Gardiner; Alex I Wandeler; Piet A Kager
Journal:  PLoS Negl Trop Dis       Date:  2009-07-28

Review 4.  Developments in rabies vaccines.

Authors:  D J Hicks; A R Fooks; N Johnson
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 5.  To Cull, or Not To Cull, Bat is the Question.

Authors:  Kevin J Olival
Journal:  Ecohealth       Date:  2015-12-02       Impact factor: 3.184

6.  A Case of Fatal Serotonin Syndrome-Like Human Rabies Caused by Tricolored Bat-Associated Rabies Virus.

Authors:  Hariharan Regunath; Bhavana Chinnakotla; Christian Rojas-Moreno; William Salzer; Natalie J Hughes; Harbaksh Sangha
Journal:  Am J Trop Med Hyg       Date:  2016-03-21       Impact factor: 2.345

7.  Rabies virus infection in Eptesicus fuscus bats born in captivity (naïve bats).

Authors:  April D Davis; Jodie A Jarvis; Craig Pouliott; Robert J Rudd
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Immunogenicity and feasibility of intradermal vaccination against rabies in Quebec.

Authors:  Y Bui; M Sow; E Cambron-Goulet; E Levac; F Milord
Journal:  Can Commun Dis Rep       Date:  2015-03-05

9.  Using serology to assist with complicated post-exposure prophylaxis for rabies and Australian bat lyssavirus.

Authors:  Niall Conroy; Susan Vlack; Julian M Williams; John J Patten; Robert L Horvath; Stephen B Lambert
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

10.  Bats, emerging infectious diseases, and the rabies paradigm revisited.

Authors:  Ivan V Kuzmin; Brooke Bozick; Sarah A Guagliardo; Rebekah Kunkel; Joshua R Shak; Suxiang Tong; Charles E Rupprecht
Journal:  Emerg Health Threats J       Date:  2011-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.